Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.

de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS.

Sci Transl Med. 2018 May 9;10(440). pii: eaar5894. doi: 10.1126/scitranslmed.aar5894.

PMID:
29743350
2.

A primary role for human central memory cells in tissue immunosurveillance.

Gehad A, Teague JE, Matos TR, Huang V, Yang C, Watanabe R, O'Malley JT, Trimble CL, Kupper TS, Clark RA.

Blood Adv. 2018 Feb 13;2(3):292-298. doi: 10.1182/bloodadvances.2017011346.

3.

Staged development of long-lived T-cell receptor αβ TH17 resident memory T-cell population to Candida albicans after skin infection.

Park CO, Fu X, Jiang X, Pan Y, Teague JE, Collins N, Tian T, O'Malley JT, Emerson RO, Kim JH, Jung Y, Watanabe R, Fuhlbrigge RC, Carbone FR, Gebhardt T, Clark RA, Lin CP, Kupper TS.

J Allergy Clin Immunol. 2017 Nov 9. pii: S0091-6749(17)31737-2. doi: 10.1016/j.jaci.2017.09.042. [Epub ahead of print]

PMID:
29128674
4.

Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.

Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O'Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS.

Nature. 2017 Mar 9;543(7644):252-256. doi: 10.1038/nature21379. Epub 2017 Feb 20.

5.

Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.

Mauldin IS, Wages NA, Stowman AM, Wang E, Olson WC, Deacon DH, Smith KT, Galeassi N, Teague JE, Smolkin ME, Chianese-Bullock KA, Clark RA, Petroni GR, Marincola FM, Mullins DW, Slingluff CL Jr.

Cancer Immunol Immunother. 2016 Oct;65(10):1201-12. doi: 10.1007/s00262-016-1880-z. Epub 2016 Aug 13.

6.

TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL.

Kirsch IR, Watanabe R, O'Malley JT, Williamson DW, Scott LL, Elco CP, Teague JE, Gehad A, Lowry EL, LeBoeuf NR, Krueger JG, Robins HS, Kupper TS, Clark RA.

Sci Transl Med. 2015 Oct 7;7(308):308ra158. doi: 10.1126/scitranslmed.aaa9122.

7.

Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.

Watanabe R, Gehad A, Yang C, Scott LL, Teague JE, Schlapbach C, Elco CP, Huang V, Matos TR, Kupper TS, Clark RA.

Sci Transl Med. 2015 Mar 18;7(279):279ra39. doi: 10.1126/scitranslmed.3010302.

8.

Alemtuzumab therapy for leukemic cutaneous T-cell lymphoma: diffuse erythema as a positive predictor of complete remission.

Watanabe R, Teague JE, Fisher DC, Kupper TS, Clark RA.

JAMA Dermatol. 2014 Jul;150(7):776-9. doi: 10.1001/jamadermatol.2013.10099. No abstract available.

9.

Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.

Maldonado L, Teague JE, Morrow MP, Jotova I, Wu TC, Wang C, Desmarais C, Boyer JD, Tycko B, Robins HS, Clark RA, Trimble CL.

Sci Transl Med. 2014 Jan 29;6(221):221ra13. doi: 10.1126/scitranslmed.3007323.

10.

Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Schlapbach C, Gehad A, Yang C, Watanabe R, Guenova E, Teague JE, Campbell L, Yawalkar N, Kupper TS, Clark RA.

Sci Transl Med. 2014 Jan 15;6(219):219ra8. doi: 10.1126/scitranslmed.3007828.

11.

TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.

Guenova E, Watanabe R, Teague JE, Desimone JA, Jiang Y, Dowlatshahi M, Schlapbach C, Schaekel K, Rook AH, Tawa M, Fisher DC, Kupper TS, Clark RA.

Clin Cancer Res. 2013 Jul 15;19(14):3755-63. doi: 10.1158/1078-0432.CCR-12-3488. Epub 2013 Jun 19.

12.

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

Dowlatshahi M, Huang V, Gehad AE, Jiang Y, Calarese A, Teague JE, Dorosario AA, Cheng J, Nghiem P, Schanbacher CF, Thakuria M, Schmults CD, Wang LC, Clark RA.

J Invest Dermatol. 2013 Jul;133(7):1879-89. doi: 10.1038/jid.2013.75. Epub 2013 Feb 18.

13.

Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas.

Gehad AE, Lichtman MK, Schmults CD, Teague JE, Calarese AW, Jiang Y, Watanabe R, Clark RA.

J Invest Dermatol. 2012 Nov;132(11):2642-51. doi: 10.1038/jid.2012.190. Epub 2012 Jun 21.

14.

Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma.

Cedeno-Laurent F, Watanabe R, Teague JE, Kupper TS, Clark RA, Dimitroff CJ.

Blood. 2012 Apr 12;119(15):3534-8. doi: 10.1182/blood-2011-12-396457. Epub 2012 Mar 1.

15.

Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.

Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC, Kupper TS.

Sci Transl Med. 2012 Jan 18;4(117):117ra7. doi: 10.1126/scitranslmed.3003008.

16.

High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.

Clark RA, Shackelton JB, Watanabe R, Calarese A, Yamanaka K, Campbell JJ, Teague JE, Kuo HP, Hijnen D, Kupper TS.

Blood. 2011 Feb 10;117(6):1966-76. doi: 10.1182/blood-2010-05-287664. Epub 2010 Dec 9.

17.

Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signaling.

Teague JE, Ryu HY, Kirber M, Sherr DH, Schlezinger JJ.

J Immunol. 2010 Sep 15;185(6):3369-78. doi: 10.4049/jimmunol.0902541. Epub 2010 Aug 18.

18.

Supplemental Content

Loading ...
Support Center